NCT02588261 2024-12-10
SOLAR
Astellas Pharma Inc
Phase 3 Terminated
Astellas Pharma Inc
Canadian Cancer Trials Group
Sichuan Provincial People's Hospital
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
AstraZeneca